sec filing
GT
NASDAQ · GTBP
GT Biopharma, Inc.
Healthcare · Biotechnology
$5.98
Up+$0.20 (+3.34%)
Updated Sep 10, 2026, 11:15 PM
SID Score
6.0/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 6.84M
- P/E ratio
- -0.27
- Dividend yield
- 0.00%
- 52-week range
- $0.26 – $7.25
- Volume
- 120.05K
- Avg. volume
- 2.07M
Price performance
GTBP price history
1M range · 20 trading sessions · Daily adjusted prices
GTBP closed at $5.98 after 20 trading sessions, up 1879.48% for the selected period.
- Last close
- $5.98
- Period change
- +1879.48%
- Period low
- $0.28
- Period high
- $7.08
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 9, 2026 | $5.47 | $6.24 | $5.12 | $5.98 | 120.05K |
| Sep 8, 2026 | $5.62 | $5.95 | $4.9101 | $5.2395 | 88.5K |
| Sep 4, 2026 | $6.4375 | $6.50 | $5.5525 | $6.025 | 46.89K |
| Sep 3, 2026 | $7.025 | $7.14 | $6.31 | $6.31 | 44.63K |
| Sep 2, 2026 | $7.00 | $7.2475 | $7.00 | $7.075 | 9.85K |
| Sep 1, 2026 | $0.29 | $0.29 | $0.28 | $0.2889 | 251.88K |
| Aug 31, 2026 | $0.31 | $0.3187 | $0.2857 | $0.286 | 314.54K |
| Aug 28, 2026 | $0.306 | $0.314 | $0.30 | $0.30 | 374.59K |
| Aug 27, 2026 | $0.295 | $0.3036 | $0.2908 | $0.3018 | 397.48K |
| Aug 26, 2026 | $0.298 | $0.298 | $0.2861 | $0.2901 | 208.7K |
| Aug 25, 2026 | $0.3145 | $0.3149 | $0.298 | $0.2997 | 441.57K |
| Aug 24, 2026 | $0.2901 | $0.318 | $0.2851 | $0.3058 | 644.3K |
| Aug 21, 2026 | $0.2822 | $0.295 | $0.2821 | $0.2886 | 253.34K |
| Aug 20, 2026 | $0.29 | $0.29 | $0.2755 | $0.282 | 197.9K |
| Aug 19, 2026 | $0.2754 | $0.29 | $0.274 | $0.2869 | 360.71K |
| Aug 18, 2026 | $0.285 | $0.285 | $0.269 | $0.2754 | 536.01K |
| Aug 17, 2026 | $0.29 | $0.2929 | $0.2814 | $0.285 | 542.42K |
| Aug 14, 2026 | $0.295 | $0.3062 | $0.2871 | $0.296 | 803.64K |
| Aug 13, 2026 | $0.3012 | $0.305 | $0.295 | $0.2974 | 512.36K |
| Aug 12, 2026 | $0.32 | $0.3205 | $0.3012 | $0.3021 | 560.1K |
Latest GTBP news
The latest Smart Investors Daily articles mentioning GTBP.
Stock researchResearch & News · SEC Filings
Loading stock research…